Lv1
60 积分 2024-05-27 加入
Novel Modic grading scoring system and its clinical validation: a preliminary investigation
2天前
已完结
Once-Weekly Mazdutide in Chinese Adults with Obesity or Overweight
11天前
已完结
Clinical characteristics and disease burden in Chinese patients with prurigo nodularis
14天前
已完结
GLOBAL EPIDEMIOLOGY OF PRIMARY BILIARY CHOLANGITIS: AN UPDATED SYSTEMATIC REVIEW AND META-ANALYSIS
14天前
已关闭
A critical analysis of Zero Trust Architecture (ZTA)
15天前
已完结
First-in-Human Study on Tolerability, Pharmacokinetics, and Pharmacodynamics of Single Escalating Doses of HEC88473, a Novel Dual GLP-1 and FGF21 Receptor Agonist in Healthy and Obese Chinese Subjects
22天前
已完结
Safety and efficacy of GLP-1/FGF21 dual agonist HEC88473 in MASLD and T2DM: a randomized, double-blind, placebo-controlled study
22天前
已完结
GLP-1 physiology in obesity and development of incretin-based drugs for chronic weight management
28天前
已完结
神经根型颈椎病诊疗规范化的专家共识
1个月前
已完结
日本骨科协会评估治疗（JOA评分）
1个月前
已完结
皖公网安备34019202002308
